LISSONI, ANDREA ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 104
EU - Europa 14
AS - Asia 5
Totale 123
Nazione #
US - Stati Uniti d'America 104
IT - Italia 6
DE - Germania 3
CN - Cina 2
NL - Olanda 2
VN - Vietnam 2
IE - Irlanda 1
IN - India 1
MK - Macedonia 1
UA - Ucraina 1
Totale 123
Città #
Santa Cruz 18
Fairfield 15
Seattle 8
Houston 6
Ashburn 4
Buffalo 4
Cambridge 4
Wilmington 3
Woodbridge 3
Chicago 2
Milan 2
Provo 2
Sesto Fiorentino 2
Ann Arbor 1
Bengaluru 1
Brooklyn 1
Clearwater 1
Denver 1
Dong Ket 1
Dublin 1
Fleming Island 1
Frankfurt am Main 1
Groningen 1
Herndon 1
Kenmore 1
Kirkland 1
Miami 1
New Kensington 1
San Diego 1
Shanghai 1
Winchester 1
Totale 91
Nome #
Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer, file e39773b7-9172-35a3-e053-3a05fe0aac26 53
Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential, file e39773b7-96c3-35a3-e053-3a05fe0aac26 43
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial, file e39773b7-9af9-35a3-e053-3a05fe0aac26 30
Clinically oriented three-step strategy to the assessment of adnexal pathology, file e39773b2-fd18-35a3-e053-3a05fe0aac26 1
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy, file e39773b3-8e97-35a3-e053-3a05fe0aac26 1
Totale 128
Categoria #
all - tutte 270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0000 00 02 10881
2021/202258 5613 70 52 21206
2022/202339 05174 26 20 3000
Totale 128